Baculovirus-Free SARS-CoV-2 Virus-like Particle Production in Insect Cells for Rapid Neutralization Assessment

Virus-like particles (VLPs) resemble authentic virus while not containing any genomic information. Here, we present a fast and powerful method for the production of SARS-CoV-2 VLP in insect cells and the application of these VLPs to evaluate the inhibition capacity of monoclonal antibodies and sera...

Full description

Bibliographic Details
Main Authors: Marcel Jaron, Michael Lehky, Marta Zarà, Chris Nicole Zaydowicz, Aidin Lak, Rico Ballmann, Philip Alexander Heine, Esther Veronika Wenzel, Kai-Thomas Schneider, Federico Bertoglio, Susanne Kempter, Reinhard Wolfgang Köster, Silvia Stella Barbieri, Joop van den Heuvel, Michael Hust, Stefan Dübel, Maren Schubert
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/14/10/2087
_version_ 1797469594857766912
author Marcel Jaron
Michael Lehky
Marta Zarà
Chris Nicole Zaydowicz
Aidin Lak
Rico Ballmann
Philip Alexander Heine
Esther Veronika Wenzel
Kai-Thomas Schneider
Federico Bertoglio
Susanne Kempter
Reinhard Wolfgang Köster
Silvia Stella Barbieri
Joop van den Heuvel
Michael Hust
Stefan Dübel
Maren Schubert
author_facet Marcel Jaron
Michael Lehky
Marta Zarà
Chris Nicole Zaydowicz
Aidin Lak
Rico Ballmann
Philip Alexander Heine
Esther Veronika Wenzel
Kai-Thomas Schneider
Federico Bertoglio
Susanne Kempter
Reinhard Wolfgang Köster
Silvia Stella Barbieri
Joop van den Heuvel
Michael Hust
Stefan Dübel
Maren Schubert
author_sort Marcel Jaron
collection DOAJ
description Virus-like particles (VLPs) resemble authentic virus while not containing any genomic information. Here, we present a fast and powerful method for the production of SARS-CoV-2 VLP in insect cells and the application of these VLPs to evaluate the inhibition capacity of monoclonal antibodies and sera of vaccinated donors. Our method avoids the baculovirus-based approaches commonly used in insect cells by employing direct plasmid transfection to co-express SARS-CoV-2 envelope, membrane, and spike protein that self-assemble into VLPs. After optimization of the expression plasmids and vector ratios, VLPs with an ~145 nm diameter and the typical “Corona” aura were obtained, as confirmed by nanoparticle tracking analysis (NTA) and transmission electron microscopy (TEM). Fusion of the membrane protein to GFP allowed direct quantification of binding inhibition to angiotensin II-converting enzyme 2 (ACE2) on cells by therapeutic antibody candidates or sera from vaccinated individuals. Neither VLP purification nor fluorescent labeling by secondary antibodies are required to perform these flow cytometric assays.
first_indexed 2024-03-09T19:23:33Z
format Article
id doaj.art-059ba81e8dae4b76b6f823fda47e7e79
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-09T19:23:33Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-059ba81e8dae4b76b6f823fda47e7e792023-11-24T03:07:12ZengMDPI AGViruses1999-49152022-09-011410208710.3390/v14102087Baculovirus-Free SARS-CoV-2 Virus-like Particle Production in Insect Cells for Rapid Neutralization AssessmentMarcel Jaron0Michael Lehky1Marta Zarà2Chris Nicole Zaydowicz3Aidin Lak4Rico Ballmann5Philip Alexander Heine6Esther Veronika Wenzel7Kai-Thomas Schneider8Federico Bertoglio9Susanne Kempter10Reinhard Wolfgang Köster11Silvia Stella Barbieri12Joop van den Heuvel13Michael Hust14Stefan Dübel15Maren Schubert16Department of Biotechnology, Technische Universität Braunschweig, Spielmannstraße 7, 38106 Braunschweig, GermanyRecombinant Protein Expression Platform, Helmholtz Centre for Infection Research, Inhoffenstraße 7, 38124 Braunschweig, GermanyUnit of Brain-Heart Axis, IRCCS Monzino Cardiology Center, Via C. Parea 4, 20138 Milano, ItalyDivision of Cellular and Molecular Neurobiology, Zoological Institute, Technische Universität Braunschweig, Spielmannstraße 7, 38106 Braunschweig, GermanyInstitute for Electrical Measurement Science and Fundamental Electrical Engineering, Technische Universität Braunschweig, Hans-Sommer-Straße 66, 38106 Braunschweig, GermanyDepartment of Biotechnology, Technische Universität Braunschweig, Spielmannstraße 7, 38106 Braunschweig, GermanyDepartment of Biotechnology, Technische Universität Braunschweig, Spielmannstraße 7, 38106 Braunschweig, GermanyAbcalis GmbH, Inhoffenstraße 7, 38124 Braunschweig, GermanyDepartment of Biotechnology, Technische Universität Braunschweig, Spielmannstraße 7, 38106 Braunschweig, GermanyDepartment of Biotechnology, Technische Universität Braunschweig, Spielmannstraße 7, 38106 Braunschweig, GermanyDepartment of Physics, Ludwig-Maximilians-Universität, Geschwister-Scholl-Platz 1, 80539 München, GermanyDivision of Cellular and Molecular Neurobiology, Zoological Institute, Technische Universität Braunschweig, Spielmannstraße 7, 38106 Braunschweig, GermanyUnit of Brain-Heart Axis, IRCCS Monzino Cardiology Center, Via C. Parea 4, 20138 Milano, ItalyRecombinant Protein Expression Platform, Helmholtz Centre for Infection Research, Inhoffenstraße 7, 38124 Braunschweig, GermanyDepartment of Biotechnology, Technische Universität Braunschweig, Spielmannstraße 7, 38106 Braunschweig, GermanyDepartment of Biotechnology, Technische Universität Braunschweig, Spielmannstraße 7, 38106 Braunschweig, GermanyDepartment of Biotechnology, Technische Universität Braunschweig, Spielmannstraße 7, 38106 Braunschweig, GermanyVirus-like particles (VLPs) resemble authentic virus while not containing any genomic information. Here, we present a fast and powerful method for the production of SARS-CoV-2 VLP in insect cells and the application of these VLPs to evaluate the inhibition capacity of monoclonal antibodies and sera of vaccinated donors. Our method avoids the baculovirus-based approaches commonly used in insect cells by employing direct plasmid transfection to co-express SARS-CoV-2 envelope, membrane, and spike protein that self-assemble into VLPs. After optimization of the expression plasmids and vector ratios, VLPs with an ~145 nm diameter and the typical “Corona” aura were obtained, as confirmed by nanoparticle tracking analysis (NTA) and transmission electron microscopy (TEM). Fusion of the membrane protein to GFP allowed direct quantification of binding inhibition to angiotensin II-converting enzyme 2 (ACE2) on cells by therapeutic antibody candidates or sera from vaccinated individuals. Neither VLP purification nor fluorescent labeling by secondary antibodies are required to perform these flow cytometric assays.https://www.mdpi.com/1999-4915/14/10/2087virus-like particles (VLPs)SARS-CoV-2insect cellsexpression vectorantibodiescellular assay
spellingShingle Marcel Jaron
Michael Lehky
Marta Zarà
Chris Nicole Zaydowicz
Aidin Lak
Rico Ballmann
Philip Alexander Heine
Esther Veronika Wenzel
Kai-Thomas Schneider
Federico Bertoglio
Susanne Kempter
Reinhard Wolfgang Köster
Silvia Stella Barbieri
Joop van den Heuvel
Michael Hust
Stefan Dübel
Maren Schubert
Baculovirus-Free SARS-CoV-2 Virus-like Particle Production in Insect Cells for Rapid Neutralization Assessment
Viruses
virus-like particles (VLPs)
SARS-CoV-2
insect cells
expression vector
antibodies
cellular assay
title Baculovirus-Free SARS-CoV-2 Virus-like Particle Production in Insect Cells for Rapid Neutralization Assessment
title_full Baculovirus-Free SARS-CoV-2 Virus-like Particle Production in Insect Cells for Rapid Neutralization Assessment
title_fullStr Baculovirus-Free SARS-CoV-2 Virus-like Particle Production in Insect Cells for Rapid Neutralization Assessment
title_full_unstemmed Baculovirus-Free SARS-CoV-2 Virus-like Particle Production in Insect Cells for Rapid Neutralization Assessment
title_short Baculovirus-Free SARS-CoV-2 Virus-like Particle Production in Insect Cells for Rapid Neutralization Assessment
title_sort baculovirus free sars cov 2 virus like particle production in insect cells for rapid neutralization assessment
topic virus-like particles (VLPs)
SARS-CoV-2
insect cells
expression vector
antibodies
cellular assay
url https://www.mdpi.com/1999-4915/14/10/2087
work_keys_str_mv AT marceljaron baculovirusfreesarscov2viruslikeparticleproductionininsectcellsforrapidneutralizationassessment
AT michaellehky baculovirusfreesarscov2viruslikeparticleproductionininsectcellsforrapidneutralizationassessment
AT martazara baculovirusfreesarscov2viruslikeparticleproductionininsectcellsforrapidneutralizationassessment
AT chrisnicolezaydowicz baculovirusfreesarscov2viruslikeparticleproductionininsectcellsforrapidneutralizationassessment
AT aidinlak baculovirusfreesarscov2viruslikeparticleproductionininsectcellsforrapidneutralizationassessment
AT ricoballmann baculovirusfreesarscov2viruslikeparticleproductionininsectcellsforrapidneutralizationassessment
AT philipalexanderheine baculovirusfreesarscov2viruslikeparticleproductionininsectcellsforrapidneutralizationassessment
AT estherveronikawenzel baculovirusfreesarscov2viruslikeparticleproductionininsectcellsforrapidneutralizationassessment
AT kaithomasschneider baculovirusfreesarscov2viruslikeparticleproductionininsectcellsforrapidneutralizationassessment
AT federicobertoglio baculovirusfreesarscov2viruslikeparticleproductionininsectcellsforrapidneutralizationassessment
AT susannekempter baculovirusfreesarscov2viruslikeparticleproductionininsectcellsforrapidneutralizationassessment
AT reinhardwolfgangkoster baculovirusfreesarscov2viruslikeparticleproductionininsectcellsforrapidneutralizationassessment
AT silviastellabarbieri baculovirusfreesarscov2viruslikeparticleproductionininsectcellsforrapidneutralizationassessment
AT joopvandenheuvel baculovirusfreesarscov2viruslikeparticleproductionininsectcellsforrapidneutralizationassessment
AT michaelhust baculovirusfreesarscov2viruslikeparticleproductionininsectcellsforrapidneutralizationassessment
AT stefandubel baculovirusfreesarscov2viruslikeparticleproductionininsectcellsforrapidneutralizationassessment
AT marenschubert baculovirusfreesarscov2viruslikeparticleproductionininsectcellsforrapidneutralizationassessment